Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge Advises Sunstone Capital on the Investment in CMC Contrast
Mandate

Vinge Advises Sunstone Capital on the Investment in CMC Contrast

February 27, 2008

Vinge advises Sunstone Capital on the investment in CMC Contrast. CMC Contrast develops the CMC 001 product. The product can be found on the market for international pharmaceuticals. The investment will contribute to further the development of the product and continued clinical studies.

Sunstone Capital is represented by partner Johan Winnerblad joined by associate Jonas Bergström.

Related

Vinge has advised Studentbostäder i Norden AB in connection with its rights issue

 Vinge has advised Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with an oversubscribed rights issue amounting to approximately SEK 145 million before deduction of transaction costs.
April 25, 2025

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

 Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025